Markets:

Overview

News

Currencies

International

Treasuries

Vivani Medical, Inc. - Common Stock (NQ:VANI)

1.430 +0.080 (+5.93%)

Streaming Delayed Price Updated: 1:51 PM EST, Dec 18, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vivani Medical, Inc. - Common Stock

< Previous 1 2 3 4 Next >

Vivani Medical Provides Update on Clinical Development Plans for Miniature, Long-term, GLP-1 Obesity Implant Program, NPM-115

July 11, 2024

From Vivani Medical, Inc.

Via Business Wire

EXCLUSIVE: Vivani Medical Outlines Plans To Kickstart First Clinical Study For Miniature GLP-1 Obesity Implant Program This Year ↗

July 11, 2024

Vivani Medical plans to start the first clinical study of the NPM-115 program in Australia in Q4 2024. The study will evaluate a 6-month GLP-1 implant for chronic weight management in obese or...

Via Benzinga

Why Signet Jewelers Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

June 13, 2024

Via Benzinga

Why GLP-1 Developer Vivani Medical's Stock Is Climbing ↗

June 13, 2024

Vivani Medical shares are trading higher Thursday after the company announced the FDA cleared the Investigational New Drug application and lifted the clinical hold on NPM-119.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

June 13, 2024

Via Benzinga

Vivani Medical Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant

June 13, 2024

From Vivani Medical, Inc.

Via Business Wire

EXCLUSIVE: Vivani Medical's Type 2 Diabetes Treatment NPM-119 Subdermal Implant's NDA Gains FDA Clearance For Clinical Use ↗

June 13, 2024

Vivani Medical cleared FDA for NPM-119 trial in type 2 diabetes. LIBERATE-1 will assess safety, tolerability, & pharmacokinetics. NPM-115 & NPM-139 also in development for weight management.

Via Benzinga

Vivani Medical Announces Publication of Positive Weight Loss Data Supporting Potential Veterinary Use of OKV-119 Miniature, Long-term GLP-1 Implant

May 28, 2024

From Vivani Medical, Inc.

Via Business Wire

EXCLUSIVE: Vivani Medical Highlights Weight Loss Data For GLP-1 Implant Supporting Potential Veterinary Use ↗

May 28, 2024

Vivani Medical announced proof-of-concept data for a subdermal exenatide implant designed for feline obesity and diabetes, which was published in BMC Veterinary Research.

Via Benzinga

VANI Stock Earnings: Vivani Medical Meets EPS for Q1 2024 ↗

May 13, 2024

VANI stock results show that Vivani Medical met analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results

May 13, 2024

From Vivani Medical, Inc.

Via Business Wire

Vivani Medical to Present at TIDES Conference 2024

May 09, 2024

From Vivani Medical, Inc.

Via Business Wire

VANI Stock Earnings: Vivani Medical Beats EPS for Q4 2023 ↗

March 26, 2024

VANI stock results show that Vivani Medical beat analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

March 26, 2024

From Vivani Medical, Inc.

Via Business Wire

Vivani Medical Appoints Daniel Bradbury to its Board of Directors

March 06, 2024

From Vivani Medical, Inc.

Via Business Wire

Vivani Medical Surges on its Ozempic-Like Weight-Loss Implant

March 06, 2024

The Ozempic craze continues to make headlines in the medical sector, and GLP-1 drug stocks such as Vivani Medical continue to surge higher

Via MarketBeat

Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 04, 2024

Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the company reported preliminary fourth-quarter financial results, announced the successful testing of its...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

March 04, 2024

Via Benzinga

Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

March 01, 2024

Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 01, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 01, 2024

Via Benzinga

Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants

March 01, 2024

From Vivani Medical, Inc.

Via Business Wire

S&P 500 Edges Lower; ADT Posts Upbeat Earnings ↗

February 28, 2024

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling around 100 points on Wednesday. The Dow traded down 0.27% to 38,867.91 while the NASDAQ fell 0.50% to 15,954.75. The...

Via Benzinga

Topics Stocks

Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

February 28, 2024

Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results.

Via Benzinga

Why Is Vivani Medical (VANI) Stock Up 300% Today? ↗

February 28, 2024

With Vivani Medical introducing pre-clinical efficacy data for its weight-loss solution, VANI stock soared on the broader implications.

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

February 28, 2024

Via Benzinga

Nasdaq Down 50 Points; US Crude Stocks Rise By 4.2M Barrels ↗

February 28, 2024

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 50 points on Wednesday. The Dow traded down 0.19% to 38,899.92 while the NASDAQ fell 0.31% to 15,985.25. The...

Via Benzinga

Topics Stocks

Dow Dips 200 Points; TJX Posts Upbeat Sales ↗

February 28, 2024

U.S. stocks traded lower this morning, with the Dow Jones index falling around 200 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.52% to 38,770.83 while the NASDAQ...

Via Benzinga

Topics Stocks

Vivani Medical Announces Positive NPM-115 Preclinical Weight Loss Data Comparable to Ozempic®/Wegovy® and Discloses NPM-139 as Semaglutide as Strategy Shifts to Prioritize Obesity Portfolio

February 28, 2024

From Vivani Medical, Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

February 28, 2024

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Vivani Medical, Inc. - Common Stock (NQ:VANI)

All News about Vivani Medical, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today